146 related articles for article (PubMed ID: 36338415)
1. Residual Inflammatory Risk and its Association With Events in East Asian Patients After Coronary Intervention.
Ahn JH; Tantry US; Kang MG; Park HW; Koh JS; Bae JS; Cho SY; Kim KH; Jang JY; Park JR; Park Y; Hwang SJ; Kwak CH; Hwang JY; Gurbel PA; Jeong YH
JACC Asia; 2022 Jun; 2(3):323-337. PubMed ID: 36338415
[TBL] [Abstract][Full Text] [Related]
2. The residual risk of inflammation and remnant cholesterol in acute coronary syndrome patients on statin treatment undergoing percutaneous coronary intervention.
Liao J; Qiu M; Su X; Qi Z; Xu Y; Liu H; Xu K; Wang X; Li J; Li Y; Han Y
Lipids Health Dis; 2024 Jun; 23(1):172. PubMed ID: 38849939
[TBL] [Abstract][Full Text] [Related]
3. Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention.
Guedeney P; Claessen BE; Kalkman DN; Aquino M; Sorrentino S; Giustino G; Farhan S; Vogel B; Sartori S; Montalescot G; Sweeny J; Kovacic JC; Krishnan P; Barman N; Dangas G; Kini A; Baber U; Sharma S; Mehran R
J Am Coll Cardiol; 2019 May; 73(19):2401-2409. PubMed ID: 31097159
[TBL] [Abstract][Full Text] [Related]
4. Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.
Kalkman DN; Aquino M; Claessen BE; Baber U; Guedeney P; Sorrentino S; Vogel B; de Winter RJ; Sweeny J; Kovacic JC; Shah S; Vijay P; Barman N; Kini A; Sharma S; Dangas GD; Mehran R
Eur Heart J; 2018 Dec; 39(46):4101-4108. PubMed ID: 30358832
[TBL] [Abstract][Full Text] [Related]
5. Combined impact of residual inflammatory risk and chronic kidney disease on long-term clinical outcomes in patients undergoing percutaneous coronary intervention.
Nishio R; Dohi T; Takeuchi M; Takahashi N; Endo H; Doi S; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
J Cardiol; 2022 Apr; 79(4):509-514. PubMed ID: 34799214
[TBL] [Abstract][Full Text] [Related]
6. Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention.
Takahashi N; Dohi T; Endo H; Funamizu T; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32268533
[TBL] [Abstract][Full Text] [Related]
7. Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events.
Klingenberg R; Aghlmandi S; Gencer B; Nanchen D; Räber L; Carballo D; Carballo S; Stähli BE; Landmesser U; Rodondi N; Mach F; Windecker S; Bucher HC; von Eckardstein A; Lüscher TF; Matter CM
Atherosclerosis; 2021 Mar; 320():31-37. PubMed ID: 33524907
[TBL] [Abstract][Full Text] [Related]
8. Association of residual inflammatory risk with stroke recurrence in patients with acute ischaemic stroke or transient ischaemic attack.
Liu H; Wang M; Xiang X; Pan Y; Li J; Meng X; Li H; Li Z; Jing J; Wang Y
Eur J Neurol; 2022 Aug; 29(8):2258-2268. PubMed ID: 35380744
[TBL] [Abstract][Full Text] [Related]
9. Residual Inflammatory Risk Predicts Poor Prognosis in Acute Ischemic Stroke or Transient Ischemic Attack Patients.
Li J; Pan Y; Xu J; Li S; Wang M; Quan K; Meng X; Li H; Lin J; Wang Y; Zhao X; Liu L; Wang Y;
Stroke; 2021 Aug; 52(9):2827-2836. PubMed ID: 34281380
[TBL] [Abstract][Full Text] [Related]
10. Effect of high-sensitivity C-reactive protein on the relationship between haemoglobin A1c and cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cohort study.
Li Y; He S; Liu T; Cheng Z; Wang C; Shi Y; Liu J
Cardiovasc Diagn Ther; 2022 Oct; 12(5):614-625. PubMed ID: 36329961
[TBL] [Abstract][Full Text] [Related]
11. Residual inflammatory risk and vulnerable plaque in the carotid artery in patients with ischemic stroke.
Gong X; Yu C; Lu Z; Wang X; Cai Q; Cheng X; Lu J
Front Neurol; 2024; 15():1325960. PubMed ID: 38721119
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and the average 30-day and 6-month clinical outcomes of patients hospitalised with coronary artery disease in a poor South-East Asian setting: the first cohort from Makassar Cardiac Center, Indonesia.
Qanitha A; Uiterwaal CSPM; Henriques JPS; Alkatiri AH; Mappangara I; Mappahya AA; Patellongi I; de Mol BAJM
BMJ Open; 2018 Jun; 8(6):e021996. PubMed ID: 29950477
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory and Cholesterol Risk in the FOURIER Trial.
Bohula EA; Giugliano RP; Leiter LA; Verma S; Park JG; Sever PS; Lira Pineda A; Honarpour N; Wang H; Murphy SA; Keech A; Pedersen TR; Sabatine MS
Circulation; 2018 Jul; 138(2):131-140. PubMed ID: 29530884
[TBL] [Abstract][Full Text] [Related]
14. Post-PCI Risk Assessment by Inflammation Activity According to Disease Acuity and Time from Procedure.
Song H; Ahn JH; Kang MG; Kim KH; Bae JS; Cho SY; Koh JS; Park Y; Hwang SJ; Cho EJ; Byeon K; Kim SW; Tantry US; Gurbel PA; Hwang JY; Jeong YH
Thromb Haemost; 2023 Jun; 123(6):627-640. PubMed ID: 36634702
[TBL] [Abstract][Full Text] [Related]
15. Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1-Year Results of the PENDULUM Registry.
Nakamura M; Kadota K; Takahashi A; Kanda J; Anzai H; Ishii Y; Shibata Y; Yasaka Y; Takamisawa I; Yamaguchi J; Takeda Y; Harada A; Motohashi T; Iijima R; Uemura S; Murakami Y;
J Am Heart Assoc; 2020 May; 9(10):e015439. PubMed ID: 32394794
[TBL] [Abstract][Full Text] [Related]
16. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.
Mani P; Puri R; Schwartz GG; Nissen SE; Shao M; Kastelein JJP; Menon V; Lincoff AM; Nicholls SJ
JAMA Cardiol; 2019 Apr; 4(4):314-320. PubMed ID: 30840024
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory risk and clinical outcomes according to polyvascular atherosclerotic disease status in patients undergoing PCI.
Bay B; Vogel B; Sharma R; Sartori S; Leone PP; Nathani M; Oliva A; Smith KF; Hooda A; Sweeny J; Dangas G; Kini A; Krishnan P; Sharma SK; Mehran R
Clin Res Cardiol; 2024 Jun; ():. PubMed ID: 38900274
[TBL] [Abstract][Full Text] [Related]
18. Ischemic and Bleeding Events Among Patients With Acute Coronary Syndrome Associated With Low-Dose Prasugrel vs Standard-Dose Clopidogrel Treatment.
Shoji S; Sawano M; Sandhu AT; Heidenreich PA; Shiraishi Y; Ikemura N; Ueno K; Suzuki M; Numasawa Y; Fukuda K; Kohsaka S
JAMA Netw Open; 2020 Apr; 3(4):e202004. PubMed ID: 32239221
[TBL] [Abstract][Full Text] [Related]
19. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein.
Leu HB; Lin CP; Lin WT; Wu TC; Chen JW
Chest; 2004 Oct; 126(4):1032-9. PubMed ID: 15486359
[TBL] [Abstract][Full Text] [Related]
20. Residual inflammatory risk predicts long-term outcomes following stenting for symptomatic intracranial atherosclerotic stenosis.
Yu Y; Lou Y; Pan Y; Yan L; Fu W; Hou Z; Cui R; Miao Z; Wang Y; Lou X; Ma N
Stroke Vasc Neurol; 2023 Aug; ():. PubMed ID: 37640497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
